» Articles » PMID: 33642439

A Resuscitated Case of Acute Myocardial Infarction with Both Familial Hypercholesterolemia Phenotype Caused by Possibly Oligogenic Variants of the PCSK9 and ABCG5 Genes and Type I CD36 Deficiency

Abstract

A 56-year-old postmenopausal woman with out-of-hospital cardiac arrest caused by acute myocardial infraction was successfully resuscitated by intensive treatments and recovered without any neurological disability. She was diagnosed as having familial hypercholesterolemia (FH) based on a markedly elevated low-density lipoprotein cholesterol (LDL-C) level and family history of premature coronary artery disease. Genetic testing in her family members showed that a variant of the proprotein convertase subtilisin/kexin type 9 (PCSK9) gene (c.2004C>A, p.S668R), which had been previously reported as having uncertain significance, was associated with FH, indicating that the variant is a potential candidate for the FH phenotype. Next-generation sequencing analysis for the proband also showed that there was a heterozygous mutation of the ATP-binding cassette sub-family G member 5 ( ABCG5) gene (c.1166G>A, R389H), which has been reported to increase LDL-C level and the risk of cardiovascular disease. She was also diagnosed as having type 1 CD36 deficiency based on a lack of myocardial uptake of I-labeled 15-(p-iodophenyl)-3-R,S-methyl-pentadecanoic acid in scintigraphy and the absence of CD36 antigen in both monocytes and platelets in flow cytometry. She had a homozygous mutation of the CD36 gene (c.1126-5_1127delTTTAGAT), which occurs in a canonical splice site (acceptor) and is predicted to disrupt or distort the normal gene product. To our knowledge, this is the first report of a heterozygous FH phenotype caused by possibly oligogenic variants of the PCSK9 and ABCG5 genes complicated with type I CD36 deficiency caused by a novel homozygous mutation. Both FH phenotype and CD36 deficiency might have caused extensive atherosclerosis, leading to acute myocardial infarction in the present case.

Citing Articles

Prognostic Value of the Selected Polymorphisms in the Gene in the Domain-Encoding Lipid-Binding Region at a 10-Year Follow-Up for Early-Onset CAD Patients.

Bartoszewicz M, Rac M Biomedicines. 2023; 11(5).

PMID: 37239003 PMC: 10216489. DOI: 10.3390/biomedicines11051332.


PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology.

Quagliariello V, Bisceglia I, Berretta M, Iovine M, Canale M, Maurea C Cancers (Basel). 2023; 15(5).

PMID: 36900189 PMC: 10000232. DOI: 10.3390/cancers15051397.


Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis.

di Taranto M, Fortunato G Int J Mol Sci. 2023; 24(4).

PMID: 36834635 PMC: 9961636. DOI: 10.3390/ijms24043224.


Acute Coronary Syndrome Developed in a 17-year-old Boy with Sitosterolemia Comorbid with Takayasu Arteritis: A Rare Case Report and Review of the Literature.

Iyama K, Ikeda S, Koga S, Yoshimuta T, Kawano H, Tsuji S Intern Med. 2021; 61(8):1169-1177.

PMID: 34615826 PMC: 9107993. DOI: 10.2169/internalmedicine.8288-21.

References
1.
Yoshida H, Tada H, Ito K, Kishimoto Y, Yanai H, Okamura T . Reference Intervals of Serum Non-Cholesterol Sterols by Gender in Healthy Japanese Individuals. J Atheroscler Thromb. 2019; 27(5):409-417. PMC: 7242229. DOI: 10.5551/jat.50187. View

2.
Masuda D, Hirano K, Oku H, Sandoval J, Kawase R, Yuasa-Kawase M . Chylomicron remnants are increased in the postprandial state in CD36 deficiency. J Lipid Res. 2008; 50(5):999-1011. PMC: 2666186. DOI: 10.1194/jlr.P700032-JLR200. View

3.
Yuasa-Kawase M, Masuda D, Yamashita T, Kawase R, Nakaoka H, Inagaki M . Patients with CD36 deficiency are associated with enhanced atherosclerotic cardiovascular diseases. J Atheroscler Thromb. 2011; 19(3):263-75. DOI: 10.5551/jat.10603. View

4.
de Ferranti S, Rodday A, Mendelson M, Wong J, Leslie L, Sheldrick R . Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES). Circulation. 2016; 133(11):1067-72. DOI: 10.1161/CIRCULATIONAHA.115.018791. View

5.
Sturm A, Knowles J, Gidding S, Ahmad Z, Ahmed C, Ballantyne C . Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel. J Am Coll Cardiol. 2018; 72(6):662-680. DOI: 10.1016/j.jacc.2018.05.044. View